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Prostasin has been shown to regulate sodium handling in the
kidney. Recently, a serine protease inhibitor, protease nexin-1
(PN-1), was identified as an endogenous inhibitor for
prostasin. Therefore, we hypothesized that PN-1 may
regulate sodium reabsorption by reducing prostasin activity,
and that expression of PN-1 was regulated by transforming
growth factor-b1 (TGF-b1) or aldosterone, like prostasin.
cRNAs for epithelial sodium channel (ENaC), prostasin,
and PN-1 were expressed in Xenopus oocytes, and the
amiloride-sensitive sodium currents (INa) were measured. The
effect of TGF-b1 and aldosterone on the mRNA and protein
abundance of PN-1 and ENaC was detected by real-time
polymerase chain reaction and immunoblotting in M-1 cells.
Expression of PN-1 substantially decreased prostasin-induced
INa by approximately 68% in oocytes. Treatment of M-1
cells with 20 ng/ml TGF-b1 significantly increased protein
expression of PN-1 by 3.870.5-fold, whereas administration
of 106 M aldosterone markedly decreased protein expression
of PN-1 to 53.776.7%. Basolateral, but not apical, application
of TGF-b1 significantly reduced Ieq. To elucidate the
involvement of PN-1 in basal ENaC activity, we silenced the
expression of PN-1 by using short-interfering RNA. This
increased Ieq by 1.670.1-fold. Our study indicates that PN-1
could have a natriuretic role by inhibiting prostasin activity
and suggests the possibility that aldosterone and TGF-b
reciprocally regulate the expression of PN-1 in renal epithelial
cells contributing to salt retention or natriuresis, respectively
by an additional mechanism. PN-1 could represent a new
factor that contributes to regulation of ENaC activity in the
kidney.
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Sodium balance, extracellular fluid volume, and ultimately
blood pressure are maintained by precise regulation of the
activity of epithelial sodium channels (ENaCs).1–3 Multiple
mechanisms such as hormones, intracellular factors, and
other regulatory factors contribute to the regulation of ENaC
activity. Prostasin, discovered in seminal fluid in 1994, is a
glycosyl-phosphatidylinositol-anchored serine protease ex-
pressed in kidney, prostate, colon, and lung, and found in
body fluids, including seminal fluid and urine.4,5 Previously,
we demonstrated that prostasin increases ENaC activity when
the two are co-expressed in Xenopus oocyte, and also showed
that an increase in urinary sodium excretion is associated
with a decrease in urinary prostasin excretion.6,7 Recently,
Chen et al.8 reported that the protease activity of prostasin is
inhibited by a serine protease inhibitor, protease nexin-1
(PN-1). PN-1 belongs to the serpin (serine protease inhi-
bitor) family and is known to be an endogenous inhibitor for
a-thrombin, plasmin, and plasminogen activators.9–11 Chen
et al.8 demonstrated that PN-1 forms sodium dodeycl sulfate
(SDS)-stable complexes with prostasin and irreversibly
inhibits its protease activity.
Transforming growth factor-b1 (TGF-b1) is a multi-
functional cytokine that regulates a wide variety of cellular
activities in many tissues and organs. TGF-b1 has been
shown to antagonize the action of aldosterone on sodium
transport by the rat inner medullary collecting ducts in
primary culture.12–15 Although the mechanism of this
antagonism is not fully understood, TGF-b1 has been
suggested to induce post-transcriptional modification of
ENaC. Previously, we showed that TGF-b1 decreases the
expression of prostasin and ENaC-mediated 22Na uptake in
M-1 cells, a mouse cortical collecting duct cell line.16
Aldosterone regulates sodium balance, extracellular fluid
volume, and blood pressure.1,17,18 It stimulates sodium
transport in the distal nephron, the distal colon, and the
ducts of exocrine glands by activating ENaC.19,20 Aldosterone
has been shown to regulate multiple cellular process leading
to the stimulation of ENaC activities such as induction of
serum and glucocorticoid-inducible kinase 1,21,22 stimulation
of K-ras,23,24 and increases the channel number of ENaC.25 In
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addition, David Pearce’s laboratory recently demonstrated
that glucocorticoid-induced leucine zipper protein is an
important aldosterone-induced regulator of ENaC activ-
ity.26,27 We previously demonstrated that aldosterone sub-
stantially increases prostasin expression in M-1 cells and rat
kidney, as well as in human kidney.28 Regulation of prostasin
expression by hormones such as TGF-b and aldosterone that
are involved in the sodium handling in the kidney suggests
the physiological importance of prostasin in the homeostasis
of the sodium balance.
Taken together, these findings suggest the possibility that
PN-1 may contribute to the regulation of sodium balance by
suppressing prostasin-stimulated ENaC activity, and that
sodium-regulating hormones such as TGF-b1 and aldoster-
one may have regulatory effects on the expression of PN-1 to
modulate sodium reabsorption in the kidney. In the present
study, we investigated the effect of PN-1 on prostasin-
mediated ENaC activation in Xenopus oocytes and the effect
of TGF-b1 and aldosterone on the expression of PN-1, ENaC
a, b, and g subunit in M-1 cells.
RESULTS
Inhibition of prostasin-induced ENaC activation by PN-1
To study the effect of PN-1 on prostasin-mediated ENaC
activation, we used the two-electrode voltage-clamp method
in Xenopus oocytes. As shown in Figure 1, expression of
ENaC a, b, and g subunits in Xenopus oocytes produced a
large inward current. Co-expression of prostasin and ENaC
markedly increased the amiloride-sensitive sodium current
(INa) as demonstrated previously (ENaC alone: 2.570.2 mA;
ENaCþ prostasin: 5.071.1 mA, Po0.05).6 Expression of
PN-1 substantially decreased prostasin-activated INa below
the level of ENaC alone (ENaCþ prostasinþ PN-1:
1.670.3 mA, Po0.01 vs ENaCþ prostasin). Also, PN-1
significantly inhibited INa under basal conditions (EN-
aCþ PN-1: 1.170.2 mA, Po0.05 vs ENaC alone).
Effect of TGF-b1 on mRNA expression of PN-1, ENaC a, b, and
c subunits in M-1 cells
Previously, we demonstrated that TGF-b1 decreased expres-
sion of prostasin mRNA and protein as well as 22Na uptake in
M-1 cells, indicating a natriuretic effect for TGF-b1.16
Therefore, in this study, we examined the effect of TGF-b1
on PN-1 and ENaC a, b, and g subunit mRNA expression in
M-1 cells. M-1 cells were treated with 20 ng/ml of TGF-b1 for
24 h and total RNA was extracted for real-time polymerase
chain reaction (PCR) analysis. Ct values for PN-1, a-ENaC,
and glyceraldehydes-3-phosphate dehydrogenase (GAPDH)
were 24.570.4, 21.170.1, and 14.970.1, respectively,
suggesting the relative abundance of PN-1 mRNA in M-1
cells. Treatment with TGF-b1 increased the expression of
PN-1 mRNA by 5.670.3-fold (Figure 2a), whereas mRNA
expression of ENaC a, b, and g subunits was decreased by
59.074.0, 80.472.1, and 52.773.4%, respectively (Figure
2b–d).
Effect of TGF-b1 on protein expression of PN-1 in M-1 cells
The anti-PN-1 antibody recognized a 43 kDa band when
blotted with recombinant mouse PN-1 (Figure 3a, left panel).
The band was completely blocked by incubation of the
antibody with the synthetic PN-1 peptide used for immu-
nization, demonstrating the specificity of the immunodetec-
tion (Figure 3a, right panel). M-1 cells were treated with
20 ng/ml of TGF-b1 for 24 h and the amount of PN-1 protein
in the culture medium was determined by immunoblotting.
As shown in Figure 3b, TGF-b1 significantly increased the
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Figure 1 | Inhibition of prostasin-induced ENaC activation by
PN-1. cRNAs coding for mouse ENaC a, b, and g subunits were
injected into Xenopus oocytes in the presence or absence of mouse
prostasin and PN-1 cRNAs. Twenty-four hours after injection,
amiloride-sensitive INa were measured by using the two-electrode
voltage-clamp system. Data are expressed as mean7s.e. (n¼ 10).
*Po0.05, **Po0.01. INa: amiloride-sensitive sodium current.
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Figure 2 | Effect of TGF-b1 on mRNA expression of PN-1 and ENaC
a, b, and c subunits. M-1 cells, which were serum-deprived for 24 h,
were treated with 20 ng/ml of TGF-b1. Twenty-four hours after
treatment, total RNA was extracted from M-1 cells and 5 mg of total
RNA was reverse-transcribed to cDNA with oligo(dT) primers. The
abundance of each mRNA was normalized for GAPDH and compared
with vehicle control ((a) PN-1, (b) a-ENaC, (c) b-ENaC, and (d) g-ENaC).
Values are expressed as fold increase over control. Data are expressed
as mean7s.d. (n¼ 6). *Po0.001 as compared with vehicle.
Kidney International (2006) 70, 1432–1438 1433
N Wakida et al.: Regulation of PN-1 by TGF-b and aldosterone o r i g i n a l a r t i c l e
expression of PN-1 protein in culture medium by 3.870.5-
fold.
Effect of TGF-b1 on sodium transport in M-1 cells
Previously, we showed that treatment of M-1 cells with TGF-
b1 substantially reduced amiloride-sensitive 22Na uptake.16
In that study, we did not address the question of whether
TGF-b1 affected ENaC activity from apical side or basolateral
side. Therefore, we measured Ieq in M-1 cells following the
application of TGF-b1 to either apical or basolateral side. As
shown in Figure 4a, basolateral, but not apical, application
of TGF-b1 strikingly reduced the Ieq (Vehicle: apical
25.971.8 mA, basolateral 24.971.9 mA; TGF-b1: apical
25.072.9 mA, basolateral 14.771.5 mA), suggesting the baso-
lateral localization of TGF-b receptors in M-1 cells. We also
determined the dose–response relationship of TGF-b1-
induced Ieq reduction (Figure 4b). The inhibitory effect of
TGF-b1 was observed in a dose-dependent manner over the
range from 0.2 to 20 ng/ml.
Effect of aldosterone on mRNA expression of PN-1, ENaC a, b,
and c subunits in M-1 cells
Next, we investigated the effects of aldosterone, a major
natriferic hormone, on PN-1 mRNA expression in M-1 cells
as we previously demonstrated that aldosterone increased the
expression of prostasin in M-1 cells. At the same time, we
also determined the effects of aldosterone on ENaC a, b, and
g subunit mRNA expression. M-1 cells were treated
with 106 M aldosterone and the expression of each mRNA
was determined using real-time PCR. Figure 5a shows that
aldosterone reduced PN-1 mRNA expression by 39.176.0%.
On the other hand, expression of ENaC a, b, and g subunit
mRNA was increased by 4.870.3, 1.670.1, and 1.470.1-
fold, respectively (Figure 5b–d).
Effect of aldosterone on protein expression of PN-1 in
M-1 cells
We also studied the effect of aldosterone on the expression of
PN-1 protein. Culture media of M-1 cells were precipitated
using trichloroacetic acid (TCA) and subjected to immuno-
blotting. As shown in Figure 6, aldosterone significantly
decreased the expression of PN-1 protein by 47.376.7%.
Effect of PN-1 gene silencing on Ieq in M-1 cells
As shown in the representative immunoblot in Figure 7a,
short-interfering RNA (siRNA) directed against PN-1
effectively reduced the PN-1 protein expression by
66.478.2% in M-1 cells. Silencing effect of siRNA was
specific for PN-1 as suggested by the lack of suppression of
PN-1 expression in cells transfected with control siRNA.
Results of pilot experiments were established 3 days after
transfection as the optimum time for studying Ieq in M-1
cells. At earlier time points, cells were recovering from
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Figure 3 | Effect of TGF-b1 on the expression of PN-1 protein in
M-1 cells. (a) The peptide absorption test for anti-PN-1 antibody.
Recombinant mouse PN-1 was probed with anti-PN-1 antibody
(left panel) or anti-PN-1 antibody preincubated with the immunizing
peptide for 16 h (right panel). (b) M-1 cells, which were
serum-deprived for 24 h, were treated with 20 ng/ml of TGF-b1 and
harvested after 24 h of incubation. Three milliliters of culture medium
were TCA-precipitated and subjected to SDS-polyacrylamide gel
electrophoresis. The expression of PN-1 protein was determined by
immunoblotting using the anti-PN-1 antibody. The bands were
quantitated with densitometry. The blot shown is representative of
five separate experiments. Values are expressed as fold increase over
control. Data are expressed as mean7s.e. (n¼ 5). *Po0.01 as
compared with vehicle.
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Figure 4 | Effect of TGF-b1 on equivalent current in M-1 cells.
(a) Effect of basolateral or apical TGF-b1 on Ieq in M-1 cells. M-1 cells
were deprived of serum for 24 h, and 20 ng/ml of TGF-b1 or vehicle
was applied to either the apical or basolateral side. Twenty-four hours
after treatment, Ieq was determined as the ratio of Vte to Rte and was
normalized by dividing Ieq by the surface area (1.13 cm) of active
membrane. Data are expressed as mean7s.e. (n¼ 6). *Po0.001.
(b) Dose-dependent effect of TGF-b1 on Ieq in M-1 cells. M-1 cells
were treated with 0.2 ng/ml to 20 ng/ml of TGF-b1 or vehicle for 24 h,
and Ieq was measured. Data are expressed as mean7s.e. (n¼ 6).
*Po0.01.
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transfection and were less likely to form high-Rte mono-
layers and were more likely to harbor residual PN-1 (data
not shown). At later time points, cells were more likely to
have escaped from the silencing by siRNA as suggested
by a relative increase in prostasin in immunoblots (data not
shown). As shown in Figure 7b, basal Ieq was increased after
transfection with PN-1 siRNA. On average, Ieq was increased
by 1.670.1-fold compared with cells transfected with
control siRNA.
DISCUSSION
In the current studies, we demonstrated that PN-1 substan-
tially inhibited the prostasin-induced ENaC activation in
Xenopus oocytes. In addition, we showed that TGF-b1 and
aldosterone reciprocally regulated the expression of PN-1,
ENaC a, b, and g subunits in M-1 cells resulting in natriuresis
or sodium retention, respectively. These findings indicate the
importance of PN-1 in the regulation of ENaC activity.
Furthermore, our current results, taken together with our
previous data regarding the regulation of prostasin expres-
sion by TGF-b1 and aldosterone, strongly suggest the
possibility that coordinated regulation of serine protease,
serpin, and ENaC expression by TGF-b1 and aldosterone
plays a key role in sodium handling in the kidney.
Hughey et al.29 demonstrated that the proteolytic proces-
sing of ENaC a and g subunits was required for the
maturation of the channel. Prostasin is one of the candidate
enzymes for processing of this channel. Previously, we
demonstrated that proteolytic activity of prostasin is involved
in the activation of ENaC in Xenopus oocytes.6 Recently,
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Figure 5 | Effect of aldosterone on mRNA expression of PN-1 and
ENaC a, b, and c subunits. M-1 cells, which were serum-deprived
for 24 h, were treated with 106 M aldosterone and harvested after
24 h of incubation. Total RNA was extracted from M-1 cell and 5 mg of
total RNA was reverse-transcribed to cDNA with oligo(dT) primers.
The abundance of each mRNA was normalized for GAPDH and
compared with vehicle control ((a) PN-1, (b) a-ENaC, (c) b-ENaC, and
(d) g-ENaC). Values are expressed as fold increase over control. Data
are expressed as mean7s.d. (n¼ 6). *Po0.001, **Po0.01 as
compared with vehicle.
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Figure 6 | Effect of aldosterone on the expression of PN-1 protein
in M-1 cells. M-1 cells were deprived of serum for 24 h and treated
with 106 M aldosterone for 24 h. Six milliliters of culture medium
were TCA-precipitated and subjected to SDS-polyacrylamide gel
electrophoresis. The expression of PN-1 protein was determined by
immunoblotting using the anti-PN-1 antibody. The bands were
quantitated with densitometry. The blot shown is representative of
six separate experiments. Values are expressed as fold increase over
vehicle-treated cells. Data are expressed as mean7s.d. (n¼ 6).
*Po0.05 as compared with vehicle.
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Figure 7 | Effect of PN-1 gene silencing with siRNA on equivalent
current in M-1 cells. (a) Representative immunoblot of PN-1 in the
culture medium from M-1 cells 72 h after incubation with PN-1 siRNA.
The first two lanes, respectively, show protein expression in cells not
exposed to siRNA and in cells incubated with control (non-silencing)
siRNA. The bands were quantitated with densitometry. The blot
shown is representative of five separate experiments. Values are
expressed as fold increase over non-treated cells. Data are expressed
as mean7s.d. (n¼ 5). *Po0.005 as compared with control siRNA.
(b) Stimulatory effect of PN-1 siRNA on basal Ieq. Seventy-two hours
after transfection with siRNA, the Ieq was measured in M-1 cells.
Values are expressed as fold increase over control siRNA. Data are
expressed as mean7s.d. (n¼ 12). *Po0.001 as compared with
control siRNA.
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Chen et al.8 isolated PN-1 as a prostasin-binding protein and
showed the inhibition of prostasin activity by PN-1 in vitro.
Here, we demonstrated the inhibition of prostasin-induced
ENaC activity by PN-1 in a heterologous expression system.
These findings suggest the physiological role of PN-1 in the
regulation of ENaC. The fact that expression of PN-1
inhibited ENaC activity under basal conditions indicated
that endogenous serine protease(s) in oocytes is/are involved
in determining the level of ENaC activity in the Xenopus
oocyte expression system. Hughey et al.29 reported that a
serine protease furin is also a candidate as an ENaC activator.
However, we do not know at this point whether PN-1 is
capable of blocking furin activity in vitro or in vivo. Further
studies are needed to elucidate this possibility. Recently,
Andreasen et al. demonstrated that ENaC is activated by
catalytically inactive prostasin in Xenopus oocytes. They
proposed a direct protein–protein interaction between
mCAP1/prostasin and an ENaC subunit or an indirect
interaction between mCAP1/prostasin and a channel-asso-
ciated extracellular protein for the mCAP1/prostasin-induced
activation of ENaC. They suggested the possibility that
mCAP1/prostasin interacts with protease inhibitors, thereby
squelching their activity on other proteases that are needed in
the catalytic pathway that leads to ENaC activation. Our
findings here would support this possibility because prostasin
could sequester PN-1 by forming SDS-stable complex and
subsequently activate ENaC. Our gene silencing effect of
PN-1 on ENaC activities would also advocate this idea.
Furthermore, they suggested another possibility that mCAP1/
prostasin serve as an extracellular signaling molecule to
induce intercellular signaling cascades independent of its
proteolytic activity. Our data also support this possibility
because binding of PN-1 to prostasin could easily affect the
affinity of prostasin to its receptor, thereby inhibiting the
prostasin-induced intracellular signaling.
TGF-b1 has been shown to reduce mineralocorticoid-
induced sodium transport in inner medullary collecting duct
cells. Previously, we demonstrated that TGF-b1 inhibited
prostasin expression at the transcriptional level and subse-
quently reduced ENaC activity in M-1 cells.16 Furthermore,
Frank et al.30 demonstrated that TGF-b1 decreased sodium
uptake by type II alveolar cells through a reduction in ENaC a
expression in an extracellular signal-regulated protein kinase
1/2-dependent manner. We showed that TGF-b1 substantially
downregulated expression of a and g-ENaC mRNA, and to a
lesser extent b-ENaC mRNA in M-1 cells. These findings
strongly support the natriuretic role of TGF-b1 in the
regulation of sodium reabsorption by kidney. In fact, a
significant correlation was observed between urinary TGF-b1
excretion and urinary sodium excretion in patients with type
II diabetes and diabetic nephropathy.31 In the current studies,
we found that TGF-b1 significantly increased PN-1 expres-
sion, which theoretically enhances the natriuretic action of
TGF-b1.
Regulation of PN-1 expression by TGF-b1 has been stud-
ied in neuronal cells although a regulatory effect of TGF-b1
on PN-1 is still controversial. Patrick et al. reported that
TGF-b1 stimulated the secretion of PN-1 by a neuroblastoma
cell line SK-N-SH,32 whereas Fabian et al. showed that
expression of PN-1 mRNA was not influenced by TGF-b1 in
astrocytic and neuronal cell cultures.33 Our finding that a
marked increase in PN-1 mRNA and protein expression by
TGF-b1 in M-1 cells is probably the first evidence showing a
regulatory effect of TGF-b1 on PN-1 in epithelial cells. The
findings that TGF-b1 increases PN-1 expression and
decreases prostasin and ENaC expression in M-1 cells
collectively suggest that TGF-b1 coordinately regulates these
three important components of renal sodium reabsorption
and favors natriuresis. Ying and Sanders reported that TGF-
b1 is synthesized in both glomeruli and tubules, and that a
high salt diet resulted in an increase in TGF-b1 production
and excretion by the kidney.34 The increased production of
TGF-b1 by the kidney and its coordinated natriuretic action
might be a compensatory response to prevent salt overload.
Aldosterone plays a pivotal role in electrolyte and fluid
homeostasis and thus control of blood pressure. Aldosterone
stimulates sodium reabsorption in the renal nephron and
distal colon by inducing several proteins such as ENaC
itself,25 K-ras,23,24 serum and glucocorticoid-inducible kinase
1,21,22 and glucocorticoid-induced leucine zipper protein.26,27
Previously, we demonstrated that aldosterone increased
prostasin expression and stimulated sodium uptake in M-1
cells, in rat kidney, and in humans28 although Liu et al.35
suggested that aldosterone does not affect prostasin levels in
M-1 cells. In this study, we found that aldosterone reduced
the expression of PN-1 mRNA and protein in renal epithelial
cells. To our knowledge, this is the first report demonstrating
regulation of PN-1 expression by aldosterone. Many
investigators have reported that the expression of a-ENaC
mRNA was increased by aldosterone.36–38 However, in some
studies, b and g subunit mRNA was increased or decreased
by aldosterone.36–38 In our hands, aldosterone induced a
substantial increase in a-ENaC mRNA expression and
relatively small increases in b and g-ENaC in M-1 cells.
Combining these aldosterone effects on PN-1, ENaC, and
prostasin could coordinately enhance sodium reabsorption
throughout the kidney.
As aldosterone has been shown to stimulate TGF-b1
production in the kidney,39 the natriuretic action of TGF-b1
could represent a compensatory response to aldosterone-
induced salt retention. Alternatively, aldosterone might be
induced to compensate for TGF-b1-mediated natriuresis,
although there is no direct evidence supporting this idea.
Reciprocal regulation of PN-1, prostasin, and ENaC by
aldosterone and TGF-b1 demonstrated in our current studies
strongly suggest the possibility that aldosterone and TGF-b1
have antagonistic effects on each other with respect to renal
sodium reabsorption.
The gene silencing experiments reported in this work, by
achieving a 1.6-fold increase in ENaC-mediated sodium
current in conjunction with a profound decrease in PN-1
expression, offer the most direct evidence that PN-1 is an
1436 Kidney International (2006) 70, 1432–1438
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important negative regulator of basal ENaC activities in
M-1 cells.
In summary, our study indicates that PN-1 could have a
natriuretic function by inhibiting prostasin activity and
suggests the possibility that aldosterone and TGF-b1
reciprocally regulate PN-1 expression in renal epithelial cells
resulting in salt retention or natriuresis, respectively. PN-1
could be considered a new factor regulating ENaC activities
in the kidney. Further studies are needed to elucidate the role
of PN-1 in regarding the body fluid composition and blood
pressure control in the kidney.
MATERIALS AND METHODS
Cell culture
M-1 cells used in this study were kind gift from Dr L Lee Hamm
(Tulane University). Cells were initially maintained in a defined
medium consisting of equal amounts of Ham’s F-12 and low-glucose
Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA,
USA), supplemented with 2 mmol/l L-glutamine, 50 U/ml penicillin,
50 mg/ml streptomycin, 5% fetal bovine serum, growth pro-
moting factors (6.25 mg/ml of transferrin, insulin, and sodium
selenite), and 100 nmol/l dexamethasone. Experiments were per-
formed when cells were confluent, and both serum and other
ingredients were removed 24 h before experiments. All studies
described in this paper were performed on cells between the fifth
and 20th passages.
cDNA cloning of mouse PN-1, ENaC a, b, and c subunits
A first-strand cDNA was synthesized from mouse kidney total RNA
with oligo(dT) primers using Superscript III (Invitrogen). Full-
length cDNAs for mouse PN-1, ENaC a, b, and g subunits were
obtained by PCR using specific oligonucleotide primers. The PCR
products were inserted into pcDNA3.1(þ ) (Invitrogen) and the
cDNA sequences were confirmed by sequencing reactions using the
dideoxy chain termination method with fluorescent dye-labeled
terminators on an automated sequencer (ABI model 310; Applied
Biosystems, Foster City, CA, USA).
Electrophysiological studies in Xenopus oocytes
cRNAs for prostasin, PN-1, and ENaC a, b, and g subunits were
synthesized using the mMESSAGE mMACHINE kit (Ambion Inc.,
Austin, TX, USA). Poly (A)þ tails were added using the Poly (A)þ
Tailing kit (Ambion) and synthesized cRNA was purified using the
MEGAclear Purification kit (Ambion). Stage 5–6 Xenopus oocytes
were treated with 1 mg/ml of collagenase type I (Sigma, St Louis,
MO, USA) for 1 h to remove follicle cell layers, and injected with
0.5 ng of cRNA for each subunit of ENaC, 1 ng of prostasin, and 5 ng
of PN-1. Electrophysiological studies were performed as described
previously.6
Real-time PCR
TaqMan probes for mouse PN-1, ENaC a, b, and g subunits, and
GAPDH were purchased from Applied Biosystems. Total RNA was
extracted from M-1 cells and 5 mg of total RNA was reverse-
transcribed to cDNA with oligo(dT) primers using Superscript III.
Real-time PCR was performed with ABI PRISM 7900 Sequence
Detector System (Applied Biosystems). Statistical analysis of results
was performed with the DCt value (Ct gene of interest–Ct GAPDH).
Relative gene expression was obtained using the DDCt method
(Ct sample–Ct calibrator).
Antibody generation
To produce the polyclonal antibody against PN-1, a short peptide
sequence, NH2-CAKIEVSEDGTKASA-COOH, that is conserved
among human, rat, and mouse was synthesized. The sequence was
chosen for specificity, antigenicity, and absence of likely post-
translational modifications using computer analysis. The peptide
was high-pressure liquid chromatography-purified, conjugated to
keyhole limpet hemocyanin, and used for immunization of rabbits
using standard immunization protocols. The resulting antisera were
affinity-purified against the immunizing peptide.
Preparation of proteins and immunoblottings
After incubation under experimental conditions, culture medium
(10 ml/10 cm dish) was collected, and centrifuged at 1200 g to pellet
cell debris. Total protein in the culture media was precipitated using
TCA (final concentration: 15%). The samples were centrifuged at
12 000 g and the pellets were washed three times with ice-cold 80%
acetone. The precipitated proteins were dried and solubilized at
1001C for 5 min in 1TCA buffer (200 mM unbuffered Tris, 1%
SDS, 10% glycerol, and 1% b-mercaptoethanol). All procedures
were performed at 41C. Samples were size fractionated on 12% SDS-
polyacrylamide gels and transferred onto nitrocellulose filters.
After blocking with 5 g/dl nonfat dry milk, the blots were probed
with a polyclonal antibody against PN-1 in Tris-buffered saline with
0.05% Tween 20 for 1 h, followed by a secondary antibody (goat
anti-rabbit immunoglobulin G-conjugated with horseradish
peroxidase) for 1 h at room temperature. Bands were visualized
using chemiluminescence substrate (enhanced chemilumine-
scence; Amersham Pharmacia Biotech, Buckinghamshire, England)
before exposure to X-ray film. The band densities were quan-
titated by densitometry (Densitograph 4.0; ATTO, Tokyo, Japan).
A positive control for anti-PN-1 antibody (recombinant mouse
PN-1) was a kind gift from Dr Karl X Chai (University of Central
Florida).
Electrophysiological transepithelial measurements
Transepithelial voltage (Vte) and resistance (Rte) were measured with
an ohm/volt meter (EVOM; World Precision Instruments, Sarasota,
FL, USA). Vte was measured by means of a set of two Ag:AgCl
electrodes and determined with the apical solution as reference. Rte
was measured by passing DC current through the cell monolayer
and measuring the resulting voltage gradient across the cells. The
equivalent current (Ieq) was calculated as the ratio of Vte to Rte and
was normalized by dividing Ieq by the surface area (1.13 cm) of
active membrane.
Application of PN-1 siRNAs
M-1 cells were transfected with PN-1 siRNA (Silencers Pre-designed
siRNA, siRNA ID#: 150952, Ambion Inc.) or control siRNA
(Silencers Negative Control #1 siRNA, Cat. #: 4635, Ambion Inc.)
by using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instruction. Twenty-four hours after transfection,
cells were deprived of serum for 48 h and Ieq was measured as
described above.
Statistical analysis
Statistical significance was evaluated using the two-tailed, paired
Student’s t-test for comparisons between two means, or analysis of
variance analysis followed by Newman–Keuls method for more than
two means. A value of Po0.05 was regarded as statistically
significant. Results are reported as mean7s.d. or s.e.
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